Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Plaque Psoriasis”

Showing 7 of 0 results

Large-scale testing (Phase 3)Study completedNCT03412747
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Plaque Psoriasis
UCB Biopharma SRL 478
Large-scale testing (Phase 3)Study completedNCT05919082
What this trial is testing

Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis

Who this might be right for
Stable Plaque Psoriasis
LEO Pharma 604
Large-scale testing (Phase 3)Study completedNCT05495568
What this trial is testing

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Celltrion 367
Early research (Phase 1)Study completedNCT03469336
What this trial is testing

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 18
Post-approval studies (Phase 4)Study completedNCT05855967
What this trial is testing

Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Eli Lilly and Company 250
Post-approval studies (Phase 4)Study completedNCT04908475
What this trial is testing

Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 352
Large-scale testing (Phase 3)Active Not RecruitingNCT06945107
What this trial is testing

Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

Who this might be right for
Plaque Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 308

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation